Intervention

Isosulfan Blue

ClinicalTrials.gov intervention label

Clinical trials2

Recruiting0

Common conditions4

Lead sponsors shown2

Clinical trials

2 shown

Axillary Reverse Mapping in Preventing Lymphedema in Patients With Breast Cancer Undergoing Axillary Lymph Node DissectionNCT03927027 · 2019-07-29

ACTIVE_NOT_RECRUITING

Injection Methods in Finding the Sentinel Lymph Node During Lymphatic Mapping and Sentinel Lymph Node Biopsy in Patients With Invasive Breast CancerNCT00438477 · 2005-06-01

COMPLETED

Common conditions

Breast Cancer1 Breast Cancer Stage I1 Breast Cancer Stage II1 Breast Cancer Stage III1

Leading sponsors

Alliance for Clinical Trials in Oncology1 M.D. Anderson Cancer Center1

Trial status mix

ACTIVE_NOT_RECRUITING1

COMPLETED1

Phase mix

NA1

PHASE31

How to interpret this record

CureCurrent links normalized diseases, medicines, registry study labels, sponsors and research sites. A link is not the same as a finding of clinical effectiveness. Our research guides explain how to compare studies, decode RxNorm identities, and avoid over-interpreting site and trial counts. See the published database coverage for mapping completeness.

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.